ÂÜÀòÂÒÂ×

Brad Klaslo has over 25 years of experience in the FDA regulated industry, with a strong focus on CAPA, ISO standards, and CBER facilities. They have managed Engineering Quality Assurance at two large gene therapy pharmaceutical companies and served as a senior technical consultant for twelve years. Previously, Brad held various positions at Abbott Laboratories, where they were instrumental in quality assurance investigations, equipment qualification, and compliance activities. Currently, Klaslo is a Senior Principal in Quality Assurance at Eli Lilly and Company, demonstrating excellent analytical skills and adaptability to evolving industry needs.